Oluwadi New Org. · AUGUST 11, 2026 · Blog ·
Oluwadi

Investigating the Overlooked

Investors Companies

Biotech / Pharma

Claris Bio

Biotech / Pharma
[subscription] Claris Bio, an eight-year-old Jersey City startup developing an experimental eye drug for limbal stem cell deficiency, raised $118 million in a Series B round co-led by Samsara BioCapital and Catalio Capital Management.. Claris Bio